
About this episode
In an interconnected world, global health is not just a scientific aspiration but an economic one. As supply shortages brought on by factory shutdowns in China demonstrate, a disease outbreak in one part of the world has ramifications on the other side of the globe. Johanna Benesty, who leads BCG’s global health work, talks about the opportunities for pharmaceutical and other health care companies in serving underserved populations in lower- and middle-income countries and elsewhere. Price is not the only barrier. Treatments may need to be redesigned to meet the realities of these countries rather than the wealthy countries where they were developed.
This podcast uses the following third-party services for analysis:
Chartable - https://chartable.com/privacy
This podcast uses the following third-party services for analysis:
Podtrac - https://analytics.podtrac.com/privacy-policy-gdrp
Get every episode summarized
Each time The So What from BCG publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The So What from BCG

What’s Keeping CEOs Up at Night?
The So What from BCG

Leading Through Scarcity: Purpose Over Panic
The So What from BCG

How Asia Is Rising as an AI Superpower
The So What from BCG

AI Profit, Not Pilots: Lessons from Tech, Media and Telecom
The So What from BCG